Osteoporosis, genetics and hormones

Journal of Molecular Endocrinology

Volumn 26, Issue 2, 2001, Pages 79-94

  Rizzoli, R ^a   Bonjour, J P ^a   Ferrari, S L ^a  

^a University Hospital   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN RECEPTOR; CALCIUM; COLECALCIFEROL; ESTROGEN; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 6; PARATHYROID HORMONE; PHOSPHATE; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D RECEPTOR;

BONE ATROPHY; BONE DENSITY; BONE MASS; BONE MINERAL; BONE REMODELING; BONE TURNOVER; CONTROLLED STUDY; ENDOCRINE FUNCTION; FEMALE; GENDER; GENETIC LINKAGE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SCREENING; HEREDITY; HORMONE ACTION; HUMAN; MALE; MENOPAUSE; NUTRITION; OSTEOPOROSIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PUBERTY; RACE DIFFERENCE; REVIEW;

BONE AND BONES; BONE DENSITY; ESTROGENS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RECEPTORS, ESTROGEN; VITAMIN D;

EID: 0035060592     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0260079     Document Type: Review

References (165)

1. Vitamin D receptor gene FokI polymorphism predicts calcium absorption and bone mineral density in children
2. Bone density and shape as determinants of bone strength in IGF-I and/or pamidronate-treated ovariectomized rats
3. Impaired muscle function with aging
4. A vitamin D receptor gene polymorphism in the translation initiation codon: Effect on protein activity and relation to bone mineral density in Japanese women
5. Histo-anatomy of the proximal femur in rats: Impact of ovariectomy on bone mass, structure and stiffness
6. Effect of estrogen deficiency on cancellous and cortical bone structure and strength of the femoral neck in rats
7. Vitamin D receptor gene polymorphisms, bone mass, body size, and vitamin D receptor density
8. Measurement of bone mineral density in mother-daughter pairs for evaluating the family influence on bone mass acquisition: A GRIO survey
9. IGF-I gene microsatellite polymorphisms and serum levels of insulin-like growth factor I (IGF-I), IGF-binding protein 3 and bone mineral density in young individuals
10. Transforming growth factor-betal gene polymorphism, bone turnover, and bone mass in Italian postmenopausal women
11. Male skeletal health and osteoporosis
12. Bone acquisition in adolescence
13. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence
14. Calcium enriched foods and bone mass growth in prepubertal girls: A randomized, double-blind, placebo-controlled trial
15. Growth factors and cytokines in bone cell metabolism
16. Effect of testosterone and estradiol in a man with aromatase deficiency
17. Elderly women accommodate to a low-protein diet with losses of body cell mass, muscle function, and immune response
18. Insulin-like growth factor I stimulates Na-dependent Pi transport in cultured kidney cells
19. Stimulatory effect of insulin-like growth factor-I on renal Pi transport and plasma 1,25-dihydroxyvitamin D3
20. Vitamin D3 and calcium to prevent hip fractures in elderly women
21. Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients
22. Arginine increases insulin-like growth factor-I production and collagen synthesis in osteoblast-like cells
23. 3
24. Bone mass in middle-aged osteoporotic men and their relatives: Familial effect
25. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis
26. Familial resemblance of bone mineral density (BMD) and calcaneal ultrasound attenuation: The BMD in mothers and daughters study
27. Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype
28. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
29. Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes
30. Bone mineral content of amenorrheic and eumenorrheic athletes
31. Suggestive linkage of the parathyroid receptor type 1 to osteoporosis
32. Lack of correlation between start codon polymorphism of the vitamin D receptor gene and bone mineral density in premenopausal French women: The OFELY study
33. Hip and calcaneal bone loss increase with advancing age: Longitudinal results from the study of osteoporotic fractures
34. Vitamin D receptor gene polymorphisms and the risk of fractures in older women
35. Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake
36. Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density
37. The vitamin D receptor gene and calcium metabolism
38. Familial resemblance for bone mineral mass is expressed before puberty
39. Do dietary calcium and age explain the controversy surrounding the relationship between bone mineral density and vitamin D receptor gene polymorphisms
40. Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: Interaction with age, dietary calcium and 3′-end region polymorphisms
41. Heritable and nutritional influences on bone mineral mass
42. Bone mineral mass and calcium and phosphate metabolism in young men: Relationships with vitamin D receptor allelic polymorphisms
43. A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women
44. Vitamin D receptor genotype and the risk of bone fractures in women
45. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis
46. Asynchrony between the rates of standing height gain and bone mass accumulation during puberty
47. Actions of insulin-like growth factors
48. Further evidence for continuing bone expansion
49. Continuing bone growth throughout life: A general phenomenon
50. Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women
51. Genetic influence on bone turnover in postmenopausal twins
52. Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: The OFELY study
53. Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: Evidence of multiple gene contribution to bone mineral density
54. Heterogeneity of growth of bone in children at the spine, radius and total skeleton
55. The association between heel ultrasound and hormone replacement therapy is modulated by a two-locus vitamin D and estrogen receptor genotype
56. Phenotype and genotype of osteoporosis
57. Vertebral bone density in children: Effect of puberty
58. Changes in vertebral bone density in black girls and white girls during childhood and puberty
59. Differential effect of gender on the sizes of the bones in the axial and appendicular skeletons
60. Differential effect of race on the axial and appendicular skeletons of children
61. A simple sequence repeat in the IGF-I gene and its relationship to serum IGF-I and peak bone mass in pupertal boys and girls
62. Measurement of bone mineral content of the lumbar spine by dual energy X-ray absorptiometry in normal children: Correlations with growth parameters
63. Association of bone dimensions with a parathyroid hormone gene polymorphism in women
64. Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13
65. Epidemiology of insulin-like factor-I in elderly men and women. The Rancho Bernardo Study
66. The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype
67. Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo study
68. Does the relationship between vitamin D receptor genotypes and bone parameters vary with physical activity level?
69. Correlates of quantitative ultrasound in the Women's Healthy Lifestyle Project
70. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women
71. Insulin-like growth factors and aging
72. Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women
73. Effects of ethnicity and age or menopause on the structure and geometry of iliac bone
74. The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women
75. The vitamin D hormone and its nuclear receptor: Molecular actions and disease states
76. A novel Van91 I polymorphism in the 1st intron of the parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor gene and its effect on the urinary cAMP response to PTH
77. Association study of parathyroid hormone gene polymorphism and bone mineral density in Japanese postmenopausal women
78. A polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucoccorticoids in vitro
79. Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus
80. Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13)
81. Relation of common allelic variation at vitamin D receptor locus to bone mineral density and postmenopausal bone loss: Cross sectional and longitudinal population study
82. Practical guide for the use of bone mineral measurements in the assessment of treatment of osteoporosis: A position paper of the European Foundation for Osteoporosis and Bone Disease. The Scientific Advisory National Societies
83. Genetic factors and osteoporotic fractures in elderly people: Prospective 25 year follow-up of a nationwide cohort of elderly Finnish twins
84. Parathyroid hormone gene polymorphisms in primary hyperparathyroidism
85. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls
86. Interaction of genetic and environmental influences on peak bone density
87. Genetic influences on bone turnover, bone density and fracture
88. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: A population-based study
89. The BsmI vitamin D receptor restriction fragment length polymorphism (bb) influences the effect of calcium intake on bone mineral density
90. Early and late postmenopausal bone loss is associated with BsmI vitamin D receptor gene polymorphism in Japanese women
91. Patients with prior fractures have an increased risk of future fractures: A summary of the literature and statistical synthesis
92. Association of bone mineral density with polymorphism of the estrogen receptor gene
93. Linkage of a QTL contributing to normal variation in bone mineral density to chromosome 11q12-13
94. Heritable and life-style determinants of bone mineral density
95. Vitamin D receptor alleles and rates of bone loss: Influences of years since menopause and calcium intake
96. A sequence variation: 713-8 delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased turnover in both osteoporotic and normal women
97. Association between insulin-like growth factor I and bone mineral density in older women and men: The Framingham Heart Study
98. Cortical bone senescence and mineral bone density of the humerus
99. Vitamin D receptor gene polymorphism is associated with birth height, growth to adolescence, and adult stature in healthy Caucasian men: A cross-sectional and longitudinal study
100. A prospective study of bone loss in African-American and white women - A clinical research center study
101. The role of IL-6 type cytokines and their receptors in bone
102. Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women
103. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis - Inference from a cross-sectional model
104. Vitamin D receptor genotypes and bone mineral density
105. Spine and femur density using dual-photon absorptiometry in US white women
106. Polymorphism of insulin-like growth factor I gene and bone mineral density
107. Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women
108. Prediction of bone density from vitamin D receptor alleles
109. Sex differences in age-related changes in vertebral body size, density and biomechanical competence in normal individuals
110. Characteristics of two novel polymorphisms at the human parathyroid hormone gene locus
111. Recombinant human PTH [rhPTH(1-34)] reduces the risk of spine and non-spine fractures in postmenopausal osteoporosis
112. Bone mass, lean mass, and fat mass: Same genes or same environments?
113. Stimulation of inorganic phosphate transport by insulin-like growth factor I and vanadate in opossum kidney cells is mediated by distinct protein tyrosine phosphorylation processes
114. Expression of a newly identified phosphate transporter/retrovirus receptor in human SaOS-2 osteoblast-like cells and its regulation by insulin-like growth factor I
115. Bone mineral mass consolidation in young British adults
116. Impact direction from a fall influences the failure load of the proximal femur as much as age-related bone loss
117. Genetic determinants of bone mass in adults. A twin study
118. Influence of vitamin D on parathyroid function in the elderly
119. What determines peak bone mass and bone loss?
120. The role of the vitamin D endocrine system in health and disease
121. Rates of bone loss in the appendicular and axial skeletons of women: Evidence for substantial vertebral bone loss before menopause
122. A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men
123. Hormones and bones
124. Dual energy X-ray absorptiometry of lumbar spine and proximal femur in the diagnosis and follow-up of osteoporosis
125. IGF-I gene 5′ polymorphism influences serum IGF-I levels in relation to dietary calcium intake in healthy young males
126. Premenopausal bone loss in the lumbar spine and neck of femur: A study of 225 Caucasian women
127. Insulin-like growth factors: Potential therapeutic options for osteoporosis
128. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: Implications for genetic studies of bone mineral density
129. Determinants of peak bone mass: Clinical and genetic analyses in a young female Canadian cohort
130. Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent
131. Determinants of premenopausal bone mineral density: The interplay of genetic and lifestyle factors
132. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: Effect of hormone replacement therapy
133. Insulin-like growth factors
134. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial
135. From density to structure: Growing up and growing old on the surfaces of bone
136. Genetic and environmental components of the population variance in bone density
137. Reduced bone mass in daughters of women with osteoporosis
138. Osteoporosis in anorexia nervosa - The influence of peak bone density, bone loss, oral contraceptive use, and exercise
139. Do genetic factors explain associations between muscle strength, lean mass, and bone density? A twin study
140. Genetic determinants of bone mass in adult women: A reevaluation of the twin model and the potential importance of gene interaction on heritability estimates
141. The genetics of proximal femur geometry, distribution of bone mass and bone mineral density
142. Sex steroids, bone mass and bone loss: A prospective study of pre-, peri-, and postmenopausal women
143. Sex steroids and bone mass in older men: Positive associations with serum estrogens and negative associations with androgens
144. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
145. Genes control the cessation of a woman's reproductive life: A twin study of hysterectomy and age at menopause
146. Genetic markers, bone mineral density, and serum osteocalcin levels
147. Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women
148. Sibling pair linkage and association studies between bone mineral density and the insulin-like growth factor I gene locus
149. Vitamin D receptor alleles predict growth and bone density in girls
150. Longitudinal monitoring of bone mass accumulation in healthy adolescents: Evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects
151. Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women
152. Sequential changes in weight, density, and percentage ash weight of human skeletons from an early fetal period through old age
153. A polymorphic CA repeat sequence at the human calcitonin locus
154. Genetic regulation of cortical and trabecular bone strength and microstructure in inbred stains of mice
155. Familial resemblance of radial bone mass between premenopausal mothers and their college-age daughters
156. A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density
157. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats
158. Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women
159. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction
160. Bone mineral density and its change in white women: Estrogen and vitamin D receptor genotypes and their interaction
161. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women
162. Transforming growth factor beta-1 gene polymorphism and bone mineral density in Japanese adolescents
163. Association of transforming growth factor beta1 genotype with therapeutic response to active vitamin D for postmenopausal osteoporosis
164. Vitamin D receptor gene polymorphisms, bone turnover, and rates of bone loss in older African-American women
165. Recent progress in understanding the genetic susceptibility to osteoporosis